UBS raised the firm’s price target on Chemours (CC) to $29 from $23 and keeps a Buy rating on the shares.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CC:
- Chemours price target raised to $27 from $21 at Truist
- Chemours price target raised to $25 from $21 at Mizuho
- Neutral Outlook on Chemours as Stable Thermal Performance Offsets Titanium Dioxide Uncertainty and Below‑Consensus 2026 EBITDA
- Chemours Completes Major 2034 Senior Notes Refinancing
- Chemours price target raised to $21 from $17 at Mizuho